Stocks
Charles River Laboratories International () CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 5.36% | 5.70% | 6.46% | 8.17% | 7.71% | 5.80% | |||
| Changes by years, y/y, % | -1pp | +0pp | +1pp | +2pp | 0pp | +4.5% | |||
Charles River Laboratories International. CAPEX/Revenue, %
Charles River Laboratories International. CAPEX/Revenue, changes, pp
Charles River Laboratories International () CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| CAPEX/Revenue, % | 6.42% | 7.73% | 7.82% | 3.85% | 3.83% | 5.80% | ||
| Changes by years, y/y, % | -1pp | 0pp | -3pp | -3pp | -3pp | |||
| Changes by quarters, q/q, % | +0pp | +1pp | +0pp | -4pp | 0pp | |||
